51 – 60 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
(
- Contribution to journal › Article
-
Mark
Effects of baseline P-wave duration and choice of atrial septal pacing site on shortening atrial activation time during pacing.
(
- Contribution to journal › Article
- 2011
-
Mark
Abnormal atrial activation in young patients with lone atrial fibrillation.
(
- Contribution to journal › Article
- 2010
-
Mark
A dedicated investigation unit improves management of syncopal attacks (Syncope Study of Unselected Population in Malmo--SYSTEMA I).
(
- Contribution to journal › Article
- 2009
-
Mark
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) Trial: clinical rationale, study design, and implementation
(
- Contribution to journal › Article
-
Mark
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
(
- Contribution to journal › Scientific review
-
Mark
Reduction of atrial fibrillation burden by atrial overdrive pacing: experience with an improved algorithm to reduce early recurrences of atrial fibrillation
(
- Contribution to journal › Article
-
Mark
Atrial fibrillatory rate and risk of stroke in atrial fibrillation.
(
- Contribution to journal › Article
- 2008
-
Mark
Percent ventricular pacing with managed ventricular pacing mode in standard pacemaker population
(
- Contribution to journal › Article
-
Mark
Fibrillatory rate response to candesartan in persistent atrial fibrillation.
(
- Contribution to journal › Article